Table of contents
Editorial
The genome-assisted barnyard - p487
doi:10.1038/nbt0609-487
In contrast to the slow translation of human genome information into medicine, animal genomics is likely to have a rapid and tangible impact on agriculture.
Abstract - | Full Text - The genome-assisted barnyard | PDF (115 KB) - The genome-assisted barnyard
News
Flu vaccine makers upgrade technology—and pray for time - pp489 - 491
Cormac Sheridan
doi:10.1038/nbt0609-489
Full Text - Flu vaccine makers upgrade technology—and pray for time | PDF (302 KB) - Flu vaccine makers upgrade technology—and pray for time
Taiwan builds biotech runway - p490
Susan Aldridge
doi:10.1038/nbt0609-490
Full Text - Taiwan builds biotech runway | PDF (91 KB) - Taiwan builds biotech runway
Profiting from pandemics - p491
Brady Huggett
doi:10.1038/nbt0609-491
Full Text - Profiting from pandemics | PDF (57 KB) - Profiting from pandemics
Boardroom tensions rise as investors push for liquidation - pp492 - 493
Brian Orelli
doi:10.1038/nbt0609-492
Full Text - Boardroom tensions rise as investors push for liquidation | PDF (209 KB) - Boardroom tensions rise as investors push for liquidation
Still strapped for cash - p493
Brady Huggett
doi:10.1038/nbt0609-493
Full Text - Still strapped for cash | PDF (115 KB) - Still strapped for cash
Mixed news for Avastin - p494
George S Mack
doi:10.1038/nbt0609-494a
Full Text - Mixed news for Avastin | PDF (273 KB) - Mixed news for Avastin
Ariad's NF
B patent claims shot down on appeal - pp494 - 495
Ken Garber
doi:10.1038/nbt0609-494b
Full Text - Ariad's NF
B patent claims shot down on appeal | PDF (315 KB) - Ariad's NF
B patent claims shot down on appeal
TNF-blocker triple approval - p495
James Netterwald
doi:10.1038/nbt0609-495
Full Text - TNF-blocker triple approval | PDF (103 KB) - TNF-blocker triple approval
Phase zero launch - p496
Emma Dorey
doi:10.1038/nbt0609-496a
Full Text - Phase zero launch | PDF (186 KB) - Phase zero launch
Pig patent revolt - p496
Anna Meldolesi
doi:10.1038/nbt0609-496b
Full Text - Pig patent revolt | PDF (186 KB) - Pig patent revolt
US regulator wades into stem cell therapies for heart disease - pp496 - 498
Randy Osborne
doi:10.1038/nbt0609-496c
Full Text - US regulator wades into stem cell therapies for heart disease | PDF (214 KB) - US regulator wades into stem cell therapies for heart disease
Genzyme takes Campath bet - p498
Brady Huggett
doi:10.1038/nbt0609-498a
Full Text - Genzyme takes Campath bet | PDF (69 KB) - Genzyme takes Campath bet
India's first true stem cell trials - p498
Killugudi Jayaraman
doi:10.1038/nbt0609-498b
Full Text - India's first true stem cell trials | PDF (69 KB) - India's first true stem cell trials
News Feature
Vaccine market boosters - pp499 - 501
Cormac Sheridan
doi:10.1038/nbt0609-499
Recent commercial success belies conventional wisdom that vaccines are a low-margin, moribund sector. But will the trend continue? Cormac Sheridan investigates.
Abstract - | Full Text - Vaccine market boosters | PDF (181 KB) - Vaccine market boosters
Bioentrepreneur
Building a business
Can you hear me in the back? - pp502 - 503
Carin Canale
doi:10.1038/bioe.2009.4
Opinion and Comment
Correspondence
Pharma's role is not to bankroll biotech - p504
Martin Mackay
doi:10.1038/nbt0609-504a
Full Text - Pharma's role is not to bankroll biotech | PDF (159 KB) - Pharma's role is not to bankroll biotech
Conflating MTAs and patents - pp504 - 505
Kevin E Noonan
doi:10.1038/nbt0609-504b
Full Text - Conflating MTAs and patents | PDF (210 KB) - Conflating MTAs and patents
Reply to Conflating MTAs and patents - p505
doi:10.1038/nbt0609-505
Full Text - Reply to Conflating MTAs and patents | PDF (214 KB) - Reply to Conflating MTAs and patents
First GM trial in Belgium since 2002 - p506
René Custers
doi:10.1038/nbt0609-506
Full Text - First GM trial in Belgium since 2002 | PDF (163 KB) - First GM trial in Belgium since 2002
A European perspective on immunogenicity evaluation - pp507 - 508
Christian K Schneider, Marisa Papaluca & Pekka Kurki
doi:10.1038/nbt0609-507
Full Text - A European perspective on immunogenicity evaluation | PDF (140 KB) - A European perspective on immunogenicity evaluation
Reflect: augmented browsing for the life scientist - pp508 - 510
Evangelos Pafilis, Seán I O'Donoghue, Lars J Jensen, Heiko Horn, Michael Kuhn, Nigel P Brown & Reinhard Schneider
doi:10.1038/nbt0609-508
Full Text - Reflect: augmented browsing for the life scientist | PDF (264 KB) - Reflect: augmented browsing for the life scientist | Supplementary information
Extrapolating from sequence—the 2009 H1N1 'swine' influenza virus - pp510 - 513
Venkataramanan Soundararajan, Kannan Tharakaraman, Rahul Raman, S Raguram, Zachary Shriver, V Sasisekharan & Ram Sasisekharan
doi:10.1038/nbt0609-510
Full Text - Extrapolating from sequence—the 2009 H1N1 'swine' influenza virus | PDF (620 KB) - Extrapolating from sequence—the 2009 H1N1 'swine' influenza virus | Supplementary information
Commentary
Science communication reconsidered - pp514 - 518
Tania Bubela, Matthew C Nisbet, Rick Borchelt, Fern Brunger, Cristine Critchley, Edna Einsiedel, Gail Geller, Anil Gupta, Jürgen Hampel, Robyn Hyde-Lay, Eric W Jandciu, S Ashley Jones, Pam Kolopack, Summer Lane, Tim Lougheed, Brigitte Nerlich, Ubaka Ogbogu, Kathleen O'Riordan, Colin Ouellette, Mike Spear, Stephen Strauss, Thushaanthini Thavaratnam, Lisa Willemse & Timothy Caulfield
doi:10.1038/nbt0609-514
As new media proliferate and the public's trust and engagement in science are influenced by industry involvement in academic research, an interdisciplinary workshop provides some recommendations to enhance science communication.
Abstract - | Full Text - Science communication reconsidered | PDF (333 KB) - Science communication reconsidered
Strangled at birth? Forest biotech and the Convention on Biological Diversity - pp519 - 527
Steven H. Strauss, Huimin Tan, Wout Boerjan & Roger Sedjo
doi:10.1038/nbt0609-519
Against the Cartagena Protocol and widespread scientific support for a case-by-case approach to regulation, the Convention on Biological Diversity has become a platform for imposing broad restrictions on research and development of all types of transgenic trees.
Abstract - | Full Text - Strangled at birth? Forest biotech and the Convention on Biological Diversity | PDF (297 KB) - Strangled at birth? Forest biotech and the Convention on Biological Diversity
Features
Masters of their universe - pp528 - 530
Randy Osborne & Laura DeFrancesco
doi:10.1038/nbt0609-528
Nature Biotechnology talks to some of the leading characters behind the Genentech legend.
Abstract - | Full Text - Masters of their universe | PDF (420 KB) - Masters of their universe
Wasting cash—the decline of the British biotech sector - pp531 - 537
Graham Smith, Muhammad Safwan Akram, Keith Redpath & William Bains
doi:10.1038/nbt0609-531
Undercapitalization and overgenerous boardroom compensation for management have been major contributors to the poor performance of UK biotech.
Abstract - | Full Text - Wasting cash—the decline of the British biotech sector | PDF (763 KB) - Wasting cash—the decline of the British biotech sector
Patents
A day late and a few million dollars short - pp538 - 541
Dianna Goldenson
doi:10.1038/nbt0609-538
The pitfalls of seeking and obtaining a patent term extension.
Abstract - | Full Text - A day late and a few million dollars short | PDF (128 KB) - A day late and a few million dollars short
Recent patent applications in genomic assays - p542
doi:10.1038/nbt0609-542
Full Text - Recent patent applications in genomic assays | PDF (57 KB) - Recent patent applications in genomic assays
News and Views
Shining light on a new class of hydrogels - pp543 - 544
Steven M Jay & W Mark Saltzman
doi:10.1038/nbt0609-543
Addition of a photodegradable group to the backbone of synthetic hydrogels enables real-time control of the material's chemical and physical properties.
Abstract - | Full Text - Shining light on a new class of hydrogels | PDF (185 KB) - Shining light on a new class of hydrogels
Cause and express - pp544 - 545
Leonid Kruglyak & John D Storey
doi:10.1038/nbt0609-544
Biological validation of a cadre of new obesity genes supports the power of studies that exploit 'expression quantitative trait loci'.
Abstract - | Full Text - Cause and express | PDF (264 KB) - Cause and express
Structure of a multidrug transporter - pp546 - 547
Michael M Gottesman, Suresh V Ambudkar & Di Xia
doi:10.1038/nbt0609-546
Crystal structures of a mammalian multidrug efflux pump bound to peptide inhibitors may reveal drug-binding sites.
Abstract - | Full Text - Structure of a multidrug transporter | PDF (647 KB) - Structure of a multidrug transporter
Research Highlights
Research highlights - p548
doi:10.1038/nbt0609-548
Full Text - Research highlights | PDF (151 KB) - Research highlights
Computational Biology
Analysis
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs - pp549 - 555
Aly A Khan, Doron Betel, Martin L Miller, Chris Sander, Christina S Leslie & Debora S Marks
doi:10.1038/nbt.1543
Transfection of siRNAs and miRNAs into cells has been observed to generate unexpected effects in the form of gene upregulation. By statistically analyzing published transfection experiments, Khan et al. explain these effects with a model that the transfected RNAs compete with miRNAs naturally expressed by the cell.
Abstract - | Full Text - Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs | PDF (543 KB) - Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs | Supplementary information
Research
Brief Communications
Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture - pp557 - 559
Michael T Forrester, J Will Thompson, Matthew W Foster, Leonardo Nogueira, M Arthur Moseley & Jonathan S Stamler
doi:10.1038/nbt.1545
Forrester et al. adapt the biotin switch technique for studying reversible protein modification by nitric oxide, by using resin-assisted capture of S-nitrosothiols. This enables more sensitive detection of larger S-nitrosylated proteins and can be coupled with quantitative mass spectrometry to study the kinetics of denitrosylation.
First Paragraph - | Full Text - Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture | PDF (219 KB) - Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture | Supplementary information
Article
Genome sequence of the recombinant protein production host Pichia pastoris - pp561 - 566
Kristof De Schutter, Yao-Cheng Lin, Petra Tiels, Annelies Van Hecke, Sascha Glinka, Jacqueline Weber-Lehmann, Pierre Rouzé, Yves Van de Peer & Nico Callewaert
doi:10.1038/nbt.1544
Pichia pastoris has been a workhorse of protein production for decades. De Schutter et al. present its genomic sequence, which will allow development of improved strains.
Abstract - | Full Text - Genome sequence of the recombinant protein production host Pichia pastoris | PDF (637 KB) - Genome sequence of the recombinant protein production host Pichia pastoris | Supplementary information
Letters
Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein - pp567 - 571
Akiko Eguchi, Bryan R Meade, Yung-Chi Chang, Craig T Fredrickson, Karl Willert, Nitin Puri & Steven F Dowdy
doi:10.1038/nbt.1541
The delivery to primary cells is a major challenge in the application of siRNAs in biological research. Using a fusion protein consisting of a double-stranded RNA binding domain and a protein transduction domain, Eguchi et al. are able to transfect siRNAs into a wide variety of cells with very high efficiency without cytotoxicity.
First Paragraph - | Full Text - Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein | PDF (438 KB) - Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein | Supplementary information
MicroRNA-mediated species-specific attenuation of influenza A virus - pp572 - 576
Jasmine T Perez, Alissa M Pham, Maria H Lorini, Mark A Chua, John Steel & Benjamin R tenOever
doi:10.1038/nbt.1542
Traditional methods for modifying viruses to produce live attenuated vaccines are being updated with molecularly targeted approaches. Perez et al. attenuate influenza A viruses by introducing miRNA target sites into the coding region of the viral genome.
First Paragraph - | Full Text - MicroRNA-mediated species-specific attenuation of influenza A virus | PDF (451 KB) - MicroRNA-mediated species-specific attenuation of influenza A virus | Supplementary information
Careers and Recruitment
Careers and Recruitment
Career interrupted - p577
Mari Paul
doi:10.1038/nbt0609-577
A sound game plan can help you roll with the punches in uncertain times.
Abstract - | Full Text - Career interrupted | PDF (78 KB) - Career interrupted



